sub1

Development path

In November 2008, 110 mu of land was newly requisitioned to build a 10,000-ton/year building material-grade hydroxypropyl methylcellulose project.

In July 2009, the construction of the first phase of sewage treatment project was completed.

In September 2009, the 10,000-ton/year building material grade hydroxypropyl methylcellulose project was completed and put into production.

In October 2010, the 5,000-ton/year medical and food grade hypromellose project was completed and put into production.

In October 2010, 90 mu of land was acquired.

In December 2010, the 5000 tons/year hydroxypropyl starch ether project was completed and put into production.

In July 2011, the 10,000 tons/year polyion cellulose project was completed and put into operation.

In December 2011, 120 mu of land was newly acquired.

In September 2012, the construction of the second phase of sewage treatment project was completed.

In October 2012, the 2500 tons/year microcrystalline cellulose project was completed and put into production.

In August 2013, the construction of Everbright Research Institute was completed and a completion ceremony was held.

In October 2013, the construction of the building material grade pilot workshop was completed.

In March 2014, the construction of the pharmaceutical auxiliary pilot workshop was completed.

In July 2014, the expansion project of the 5,000 tons/year pharmaceutical and food grade hypromellose project was completed and put into production.

In May 2015, the 10,000-ton/year polyanionic cellulose reconstruction K brand hydroxypropyl methylcellulose project was completed and put into production.

In June 2015, the construction of the third phase of sewage treatment project was completed.

In September 2015, the low-substituted hydroxypropyl cellulose project for pharmaceutical excipients was completed.

In May 2016, the construction of the third phase of sewage treatment renovation project was completed.